The webinar held on May 11, 2022 focused on how to implement high-quality, harmonized RWD/RWE networks for cancer research, decision making and regulatory purposes. The key questions addressed included the integration of academic and commercial RWD sources for fit-for-purpose, accessable RWE generation, and data structures and models best supportive of recent EU regulation (GDPR, EHDS).
| RECORDINGS | PRESENTER | |
| Observational Cancer Research: Challenges and Opportunities | Asieh Golozar VP, Global Head of Data Science, Odysseus Data Services; Professor of the Practice and Director of Clinical Research at the OHDSI Center, Northeastern University |  |
| European health data spaces (slides in pdf format) | Nigel Hughes Scientific Director, Observational Health Data Analytics / Epidemiology, Janssen Research and Development Commentar remarks: Juho Immonen, Novartis |  |
| Private sector as a provider of RWD and RWE | Michael Bierl GM Europe, Flatiron Health |  |
| Improving patient outcomes through patient-generated evidence | Jan Geissler CEO, Patvocates; Vice President, Leukemia Patient Advocates Foundation; Co-Founder, CML Advocates Network, Ex-Director, EUPATI |  |
| Swarm learning for decentralized and confidential clinical machine learning | Joachim Schultze Professor, Director Systems Medicine at DZNE; Director, Genomics & Immunoregulation, LIMES-Institute, University of Bonn, Germany |  |
